BSE filing, NSE: BERLDRG. Summary written from the filing by ALFA Finder's alert engine.
Beryl Drugs Ltd: key numbers
- Share price
- ₹25.00
- Market cap
- ₹12.68 Cr
- Revenue (annual)
- ₹18.82 Cr
- Net profit (annual)
- ₹0.42 Cr
- P/E (TTM)
- 20.3×Sector 46.1×
- Promoter holding
- 27.97%+0.15% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Beryl Drugs Ltd
All →Beryl Drugs Other Announcement
Beryl Drugs Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Beryl Drugs Other Announcement
Beryl Drugs Limited has submitted its quarterly compliance certificates regarding Regulation 74(5) and a non-applicability confirmation for Regulation 57(5) for the quarter ended September 30, 2026.
Beryl Drugs Annual General Meeting
Beryl Drugs Limited held its 33rd Annual General Meeting on September 29, 2026. Shareholders approved audited financial statements, director reappointment, and increased related-party transaction limits.
Beryl Drugs Annual Report
Beryl Drugs Ltd has submitted its 33rd Annual Report for the financial year 2025-26, scheduled for its upcoming Annual General Meeting.
Beryl Drugs Annual General Meeting
Beryl Drugs Ltd has announced the closure of its register of members from September 23 to September 29, 2026, for its 33rd Annual General Meeting.
Beryl Drugs Board Meeting Outcome
Beryl Drugs Limited approved items for its 33rd Annual General Meeting and a proposal to increase material related party transaction limits.
Other board meeting date announcements
All →Trigyn Technologies Board Meeting Date
Trigyn Technologies will hold a board meeting on November 4, 2026 to approve unaudited quarterly results. Agenda items are only proposed at this stage.
VJTF Eduservices Board Meeting Date
VJTF Eduservices intimated a board meeting on 6 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The notice is a prior intimation with agenda only proposed.
Utkarsh Small Finance Bank Board Meeting Date
Utkarsh Small Finance Bank gave intimation of a board meeting on November 3, 2026 to consider Q2 and H1 unaudited results. The trading window reopens November 6, 2026.
Gala Global Products Board Meeting Date
Gala Global Products has given advance notice of a board meeting on 3 November 2026 to consider unaudited standalone results for the quarter ended 30 September 2026. The trading window is closed from 1 October 2026 until 48 hours after the results are made public.
Suncity Synthetics Board Meeting Date
Suncity Synthetics Limited has given advance notice of a board meeting on 3 November 2026 to consider its unaudited standalone results for the quarter ended September 30, 2026. No financial figures are disclosed in this intimation.
Ambar Protein Industries Board Meeting Date
Ambar Protein will hold a board meeting on November 5, 2026 to consider quarterly results. Trading window closes for insiders until 48 hours after results.